Provided by Tiger Fintech (Singapore) Pte. Ltd.

AstraZeneca PLC

75.57
+1.331.79%
Post-market: 75.49-0.0800-0.11%19:54 EDT
Volume:6.67M
Turnover:502.55M
Market Cap:234.36B
PE:33.59
High:75.79
Open:75.27
Low:74.68
Close:74.24
Loading ...

Bank of America Securities Remains a Buy on AstraZeneca (AZN)

TIPRANKS
·
20 Jan

FDA Approves Two Breakthrough Cancer Treatments for AstraZeneca

GuruFocus.com
·
20 Jan

AstraZeneca Trial Results In Focus Amid China Sales Concerns -- Market Talk

Dow Jones
·
20 Jan

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

TipRanks
·
18 Jan

AstraZeneca Gets FDA Approval for Metastatic Breast Cancer Treatment Datroway

Dow Jones
·
18 Jan

DATROWAY® (datopotamab deruxtecan-dlnk) approved in the US for patients with previously treated metastatic HR-positive, HER2-negative breast cancer

Business Wire
·
18 Jan

Pharma Stock Roundup: J&J's ITCI Buyout, LLY's Weak Q4 Sales

Zacks
·
18 Jan

Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations

Benzinga
·
18 Jan

AstraZeneca PLC Stock Rises Friday, Outperforms Market

Dow Jones
·
18 Jan

Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations

Yahoo Finance
·
17 Jan

AstraZeneca overhauls management of its scandal-hit China division

Financial Times
·
17 Jan

Astrazeneca Says Mantle Cell Lymphoma Combination Treatment Receives FDA Approval

MT Newswires Live
·
17 Jan

CALQUENCE® (acalabrutinib) plus chemoimmunotherapy approved in the US for patients with previously untreated mantle cell lymphoma

Business Wire
·
17 Jan

AstraZeneca’s Calquence combination approved in U.S.

TIPRANKS
·
17 Jan

When market concentration bites. Europe's GRANOLAs offer a lesson for U.S. investors, says Goldman.

Dow Jones
·
17 Jan

Kepler Capital Remains a Hold on AstraZeneca (AZN)

TIPRANKS
·
17 Jan